Metastatic Cancer Treatment Market Report

Global and Region Metastatic Cancer Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：172
  • REPORT CODE：GMM932529
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.

    The report details the trend, potential and market size of Metastatic Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Metastatic Cancer Treatmentmarket, defines the market attractiveness level of Metastatic Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Metastatic Cancer Treatment industry, describes the types of Metastatic Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Metastatic Cancer Treatment market and the development prospects and opportunities of Metastatic Cancer Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Metastatic Cancer Treatment market in Chapter 13.

    By Player:

    • Bristol Myers Squibb Company

    • Bayer AG

    • Novartis AG

    • Amgen Inc

    • AbbVie Inc

    • AstraZeneca PLC

    • F Hoffmann-La Roche AG

    • Merck & Co Inc

    • Johnson & Johnson

    • Pfizer Inc

    By Type:

    • Chemotherapy

    • Radiation Therapy

    • Biologic Targeted Therapy

    • Breast Surgery

    • Hormone Therapy

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Metastatic Cancer Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Metastatic Cancer Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Metastatic Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Metastatic Cancer Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Metastatic Cancer Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Metastatic Cancer Treatment Consumption (2017-2022)

    • 7.2 United States Metastatic Cancer Treatment Consumption (2017-2022)

    • 7.3 Europe Metastatic Cancer Treatment Consumption (2017-2022)

    • 7.4 China Metastatic Cancer Treatment Consumption (2017-2022)

    • 7.5 Japan Metastatic Cancer Treatment Consumption (2017-2022)

    • 7.6 India Metastatic Cancer Treatment Consumption (2017-2022)

    • 7.7 South Korea Metastatic Cancer Treatment Consumption (2017-2022)

    8 Region and Country-wise Metastatic Cancer Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Metastatic Cancer Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Metastatic Cancer Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Metastatic Cancer Treatment Consumption Forecast (2022-2028)

    • 8.4 China Metastatic Cancer Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Metastatic Cancer Treatment Consumption Forecast (2022-2028)

    • 8.6 India Metastatic Cancer Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Metastatic Cancer Treatment Consumption Forecast (2022-2028)

    9 Global Metastatic Cancer Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Metastatic Cancer Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Biologic Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Breast Surgery Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Hormone Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Metastatic Cancer Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Metastatic Cancer Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Metastatic Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Biologic Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Breast Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Metastatic Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Metastatic Cancer Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Metastatic Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Metastatic Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Metastatic Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Metastatic Cancer Treatment Market Competitive Analysis

    • 14.1 Bristol Myers Squibb Company

      • 14.1.1 Bristol Myers Squibb Company Company Details

      • 14.1.2 Bristol Myers Squibb Company Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol Myers Squibb Company Metastatic Cancer Treatment Product and Service

    • 14.2 Bayer AG

      • 14.2.1 Bayer AG Company Details

      • 14.2.2 Bayer AG Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer AG Metastatic Cancer Treatment Product and Service

    • 14.3 Novartis AG

      • 14.3.1 Novartis AG Company Details

      • 14.3.2 Novartis AG Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG Metastatic Cancer Treatment Product and Service

    • 14.4 Amgen Inc

      • 14.4.1 Amgen Inc Company Details

      • 14.4.2 Amgen Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amgen Inc Metastatic Cancer Treatment Product and Service

    • 14.5 AbbVie Inc

      • 14.5.1 AbbVie Inc Company Details

      • 14.5.2 AbbVie Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AbbVie Inc Metastatic Cancer Treatment Product and Service

    • 14.6 AstraZeneca PLC

      • 14.6.1 AstraZeneca PLC Company Details

      • 14.6.2 AstraZeneca PLC Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca PLC Metastatic Cancer Treatment Product and Service

    • 14.7 F Hoffmann-La Roche AG

      • 14.7.1 F Hoffmann-La Roche AG Company Details

      • 14.7.2 F Hoffmann-La Roche AG Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 F Hoffmann-La Roche AG Metastatic Cancer Treatment Product and Service

    • 14.8 Merck & Co Inc

      • 14.8.1 Merck & Co Inc Company Details

      • 14.8.2 Merck & Co Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merck & Co Inc Metastatic Cancer Treatment Product and Service

    • 14.9 Johnson & Johnson

      • 14.9.1 Johnson & Johnson Company Details

      • 14.9.2 Johnson & Johnson Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson Metastatic Cancer Treatment Product and Service

    • 14.10 Pfizer Inc

      • 14.10.1 Pfizer Inc Company Details

      • 14.10.2 Pfizer Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Pfizer Inc Metastatic Cancer Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Metastatic Cancer Treatment

    • Figure Metastatic Cancer Treatment Picture

    • Table Global Metastatic Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metastatic Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metastatic Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Metastatic Cancer Treatment Consumption by Country (2017-2022)

    • Figure United States Metastatic Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Metastatic Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Metastatic Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Metastatic Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Metastatic Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Metastatic Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Metastatic Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Metastatic Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Metastatic Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Metastatic Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Metastatic Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Metastatic Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Metastatic Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Biologic Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biologic Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Metastatic Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Metastatic Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Company Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Company Metastatic Cancer Treatment Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Metastatic Cancer Treatment Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Metastatic Cancer Treatment Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Metastatic Cancer Treatment Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Metastatic Cancer Treatment Product and Service

    • Table AstraZeneca PLC (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca PLC Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca PLC Metastatic Cancer Treatment Product and Service

    • Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche AG Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche AG Metastatic Cancer Treatment Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Metastatic Cancer Treatment Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Metastatic Cancer Treatment Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Metastatic Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Metastatic Cancer Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US